The DOI matches its Crossref record; 102 of the 106 references it cites were found in a registry or an index.
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system
Open accessAbstract
In 2019-2020 a new coronavirus named SARS-CoV-2 was identified as the causative agent of a several acute respiratory infection named COVID-19, which is causing a worldwide pandemic. There are still many unresolved questions regarding the pathogenesis of this disease and especially the reasons underlying the extremely different clinical course, ranging from asymptomatic forms to severe manifestations, including the Acute Respiratory Distress Syndrome (ARDS). SARS-CoV-2 showed phylogenetic similarities to both SARS-CoV and MERS-CoV viruses, and some of the clinical features are shared between COVID-19 and previously identified beta-coronavirus infections. Available evidence indicate that the so called "cytokine storm" an uncontrolled over-production of soluble markers of inflammation which, in turn, sustain an aberrant systemic inflammatory response, is a major responsible for the occurrence of ARDS. Chemokines are low molecular weight proteins with powerful chemoattractant activity which play a role in the immune cell recruitment during inflammation. This review will be aimed at providing an overview of the current knowledge on the involvement of the chemokine/chemokine-receptor system in the cytokine storm related to SARS-CoV-2 infection. Basic and clinical evidences obtained from previous SARS and MERS epidemics and available data from COVID-19 will be taken into account.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“T helper (Th)-1 cytokines, including Interleukin (IL)-1β, IL-6, Interferon (IFN)-γ, Tumor Necrosis Factor (TNF)-α, CXCL10, and CCL2; and Th-2 cytokines, including IL-4, IL-10, and IL-1 receptor antagonist are all elevated in the serum of COVID-19 patients (Coperchini et al., 2020) in a “cytokine storm” typically associated with the illness.”
From Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up (2021) · cites this paper as Coperchini et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,332
Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0504 · Cited by 5,970
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,910
The reproductive number of COVID-19 is higher compared to SARS coronavirus
Liu, Y., Gayle, A. A., Wilder‐Smith, A., & Rocklöv, J. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa021 · Cited by 3,243
Cited by
Sorted by citations
Items 701–800 of 1,000
Alabd, S., & Mahmoud, A. (2021) · Journal of Bioscience and Applied Research/Journal of Bioscience and Applied Research · doi:10.21608/jbaar.2021.251241 · Cited by 8
Almada, L., Angiolini, S. C., Dho, N. D., Dutto, J., Gazzoni, Y., Manzone-Rodríguez, C., Marín, C., Ponce, N. E., Arroyo, D. S., Quiroz, J. N., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1111797 · Cited by 8
The potential of Panax notoginseng against COVID-19 infection
Hu, Y., He, Z., Zhang, W., Niu, Z., Wang, Y., Zhang, J., Shen, T., Cheng, H., & Hu, W. (2023) · Journal of Ginseng Research · doi:10.1016/j.jgr.2023.04.002 · Cited by 8
Simonetti, A., Bernardi, E., Margoni, S., Catinari, A., Restaino, A., Ieritano, V., Palazzetti, M., Mastrantonio, F., Janiri, D., Tosato, M., et al. (2023) · Brain Sciences · doi:10.3390/brainsci13040688 · Cited by 8
Yang, X., Wang, C.-X., Wang, J., Wu, S., Yong, Q., Li, K., & Yang, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1188086 · Cited by 8
Rohilla, D., Srivastava, A. K., Singh, R. P., Yadav, P., Singh, S. K., Kumar, D., Bhardwaj, N., Kesawat, M. S., Pandey, K. D., & Kumar, A. (2023) · Stresses · doi:10.3390/stresses3030039 · Cited by 8
Wang, B., Li, D., Fiselier, A., Kovalchuk, I., & Kovalchuk, O. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18817 · Cited by 8
Zhang, Z., Tao, W., Cheng, D., Qin, M., Fu, J., & Liu, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1197493 · Cited by 8
Chemokine CCL2 and its receptor CCR2 in different age groups of patients with COVID-19
Bagheri, V., Khorramdelazad, H., Kafi, M., & Abbasifard, M. (2024) · BMC Immunology · doi:10.1186/s12865-024-00662-8 · Cited by 8
Comparative Study of Cytokine Profiles in SARS-CoV-2 Delta and Omicron Variants
Krivosova, M., Hanusrichterová, J., Lučanský, V., Samec, M., Bobčáková, A., Baranovičová, E., Dohál, M., Mokrý, J., Škereňová, M., Lipták, P., et al. (2025) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/s44411-024-00010-7 · Cited by 8
Roy, S., & MainakMukhopadhyay (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00370-5 · Cited by 8
Valk, T. W., & McMorrow, C. (2020) · SAGE Open Medicine · doi:10.1177/2050312120974174 · Cited by 8
Tiwari‐Heckler, S., Rauber, C., Longhi, M. S., Zörnig, I., Schnitzler, P., Jäger, D., Giese, T., & Merle, U. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab019 · Cited by 8
Puzyrenko, A., Felix, J. C., Sun, Y., Rui, H., & Sheinin, Y. M. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153380 · Cited by 8
Learning From the Experiences of COVID-19 Survivors: Web-Based Survey Study
Prioleau, T. (2021) · JMIR Formative Research · doi:10.2196/23009 · Cited by 8
Kumari, P., & Arun, S. (2021) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23787 · Cited by 8
Das, S., Pearson, M. W., Taylor, K., Bouchet, V., Møller, G. L., Hall, T. O., Strivens, M. A., Tzeng, K., & Gardner, S. (2021) · Frontiers in Digital Health · doi:10.3389/fdgth.2021.660809 · Cited by 9
Scalable workflow for characterization of cell-cell communication in COVID-19 patients
Lin, Y., Loo, L., Tran, A., Lin, D. M., Moreno, C. L., Hesselson, D., Neely, G. G., & Yang, J. Y. H. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010495 · Cited by 8
Huang, Y., Wang, Y., Xu, D., Xiao, L., Qin, W., Liu, B., & Yuan, X. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.995736 · Cited by 8
Fallah, A., Sedighian, H., Behzadi, E., Havaei, S. A., Kachuei, R., & Fooladi, A. A. I. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105888 · Cited by 8
Supriya, R., Singh, K. P., Gao, Y., Tao, D., Cheour, S., Dutheil, F., & Baker, J. S. (2022) · Biology · doi:10.3390/biology12010006 · Cited by 8
Does COVID-19 Escalate Aging Process? A Possible Concern
Tayeri, K., Asadollahi, K., Madani, N., & Javanmard, S. H. (2022) · Advanced Biomedical Research · doi:10.4103/abr.abr_350_21 · Cited by 8
Treatment options for patients with severe COVID-19
Morishita, M., & Hojo, M. (2023) · Global Health & Medicine · doi:10.35772/ghm.2023.01024 · Cited by 8
hWJMSCs inhibit inflammation and apoptosis in an ARDS cell model
Widowati, W., Wargasetia, T. L., Rahardja, F., Gunanegara, R. F., Priyandoko, D., Gondokesumo, M. E., Novianto, A., Yati, A., & Rizal, R. (2023) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2023.06.007 · Cited by 8
Ghaleh, H. E. G., Izadi, M., Javanbakht, M., Ghanei, M., Einollahi, B., Jafari, N. J., Alishiri, G. H., Aslani, J., Abolghasemi, H., Simonetti, V., et al. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01288-9 · Cited by 8
Overview of management of children with COVID-19
Wati, D. K., & Manggala, A. K. (2020) · Korean Journal of Pediatrics · doi:10.3345/cep.2020.00913 · Cited by 8
Characteristics and Developments in Mesenchymal Stem Cell Therapy for COVID-19: An Update
Sang, L., Guo, X., Shi, J., Hou, S., Fan, H., & Lv, Q. (2021) · Stem Cells International · doi:10.1155/2021/5593584 · Cited by 8
Two-Step In Vitro Model to Evaluate the Cellular Immune Response to SARS-CoV-2
Melgaço, J. G., Azamor, T., da Silva, A. M. V., Linhares, J., Santos, T. P., Mendes, Y. S., de Lima, S. M. B., Fernandes, C. B., da Silva, J., de Souza, A. P., et al. (2021) · Cells · doi:10.3390/cells10092206 · Cited by 8
Hu, X., Niu, Y., Luo, P., Xiao, F., Yuan, F., Yin, H., Chen, S., & Guo, F. (2022) · Communications Biology · doi:10.1038/s42003-022-03609-0 · Cited by 9
Tissue repair strategies: What we have learned from COVID-19 in the application of MSCs therapy
Li, Y. E., Ajoolabady, A., Dhanasekaran, M., & Ren, J. T. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106334 · Cited by 8
Seth, P., & Sarkar, N. (2022) · 3 Biotech · doi:10.1007/s13205-022-03390-1 · Cited by 6
Lan, H., Zhou, Z., Hu, Q., Xie, Q., Li, X., Tian, T., Wang, Y., Yang, C., Kong, L., Fu, D., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-03058-3 · Cited by 8
Sârbu, F., Oprea, V. D., Tatu, A. L., Drima, E. P., Ștefănescu, C., Nechita, A., Onose, G., & Romila, A. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11424 · Cited by 7
Late Complications of COVID-19; An Umbrella Review on Current Systematic Reviews.
SeyedAlinaghi, S., Bagheri, A. B., Razi, A., Mojdeganlou, P., Mojdeganlou, H., Afsahi, A. M., Afzalian, A., Paranjkhoo, P., Shahidi, R., Mirzapour, P., et al. (2023) · Archives of Academic Emergency Medicine · doi:10.22037/aaem.v11i1.1907 · Cited by 7
Chemokine Levels among Patients with Middle East Respiratory Syndrome Coronavirus Infection
Alhetheel, A., Albarrag, A., Shakoor, Z. A., Somily, A. M., Barry, M. A., Altalhi, H., Bakhrebah, M. A., Nassar, M. S., Al‐Fageeh, M. B., Asiri, A. Y., et al. (2023) · Vaccines · doi:10.3390/vaccines11061048 · Cited by 7
Yazdanparast, S., Bakhtiyaridovvombaygi, M., Mikanik, F., Ahmadi, R., Ghorbani, M., Mansoorian, M. R., Mansoorian, M., Chegni, H., Moshari, J., & Gharehbaghian, A. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121907 · Cited by 7
COVID myocarditis: a review of the literature
Cersosimo, A., Pasquale, M. D., Arabia, G., Metra, M., & Vizzardi, E. (2023) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2023.2784 · Cited by 7
Decreased progenitor TCF1 + T-cells correlate with COVID-19 disease severity
Tu, T. H., Grunbaum, A., Santinon, F., Kazanova, A., Rozza, N., Kremer, R. B., Mihalcioiu, C. L. D., & Rudd, C. E. (2024) · Communications Biology · doi:10.1038/s42003-024-05922-2 · Cited by 7
Agamah, F. E., Ederveen, T. H. A., Skelton, M., Martin, D. P., Chimusa, E. R., & Hoen, P. A. C. ’. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1393240 · Cited by 8
Raddad, Y., Hasasneh, A., Abdallah, O., Rishmawi, C., & Qutob, N. (2024) · Big Data and Cognitive Computing · doi:10.3390/bdcc8120192 · Cited by 7
Acehan, S., Gülen, M., Isıkber, C., Kaya, A., Ünlü, N., İnce, Ç., Firat, B. T., Sahin, G. K., Sümbül, H. E., & Satar, S. (2021) · Çukurova medical journal (Online)/Çukurova medical journal · doi:10.17826/cumj.977050 · Cited by 7
Association of weekly or biweekly use of 50 000 IU vitamin D3 with hypervitaminosis D
Hashemipour, S., Ghobadi, A., Khairkhahan, S. M. R. H., Ranjbaran, M., Badri, M., Ghafelehbashi, H., & Gheraati, M. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15186 · Cited by 7
Blood filters in children with COVID ‐19 and acute kidney injury: A review
Raina, R., Sethi, S. K., Chakraborty, R., Singh, S., Teo, S., Khooblall, A., Montini, G., Bunchman, T. E., Topaloğlu, R., & Yap, H. K. (2022) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.13793 · Cited by 7
Yadav, D., Agarwal, S., Pancham, P., Jindal, D., Agarwal, V., Dubey, P. K., Jha, S. K., Mani, S., Rachana, R., Dey, A., et al. (2022) · Immuno · doi:10.3390/immuno2020022 · Cited by 7
Opioid-Use, COVID-19 Infection, and Their Neurological Implications
Jalodia, R., Antoine, D., Braniff, R. G., Dutta, R. K., Ramakrishnan, S., & Roy, S. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.884216 · Cited by 7
Swartzman, I., Gu, J. J., Toner, Z., Grover, R. K., Suresh, L., & Ullman, L. E. (2022) · Cureus · doi:10.7759/cureus.29752 · Cited by 7
Mendes‐Frias, A., Gallo, V., Iacobelli, V., Gentile, R., Antonini, G., Silvestre, R., & Iacobelli, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-20852-x · Cited by 7
Balkrishna, A., Goswami, S., Singh, H., Gohel, V., Dev, R., Haldar, S., & Varshney, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1024830 · Cited by 7
Whole-transcriptome analyses of sheep embryonic testicular cells infected with the bluetongue virus
Lu, D., Li, Z., Zhu, P., Yang, Z., Yang, H., Li, Z., Li, H., & Li, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1053059 · Cited by 7
Amer, O. E., Sabico, S., Sheshah, E., Alotaibi, N. H., Aldisi, D. A., Enani, M. A., Aljohani, N. J., Alshingetti, N. M., Alomar, S. Y., Hussain, S. D., et al. (2022) · Healthcare · doi:10.3390/healthcare10122571 · Cited by 7
The role of HLA genotypes in understanding the pathogenesis of severe COVID-19
Arab, F., Mollazadeh, S., Ghayourbabaei, F., Moghbeli, M., & Saburi, E. (2023) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-023-00392-3 · Cited by 7
Puchongmart, C., Boonmee, P., Jirathanavichai, S., Phanprasert, N., Thirawattanasoot, N., Dorongthom, T., Monsomboon, A., Praphruetkit, N., & Ruangsomboon, O. (2023) · International Journal of Emergency Medicine · doi:10.1186/s12245-023-00482-4 · Cited by 7
COVID-19: Variants, Immunity, and Therapeutics for Non-Hospitalized Patients
Lee, C. Y. S., & Suzuki, J. B. (2023) · Biomedicines · doi:10.3390/biomedicines11072055 · Cited by 7
Type 2 diabetes and Covid-19: Lessons learnt, unanswered questions and hints for the future
Nazari, P., & Pozzilli, P. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110896 · Cited by 7
Esa, T., Budu, B., Mulyono, B. E., Soraya, G. V., Usman, A. N., & Intansari, U. S. (2023) · F1000Research · doi:10.12688/f1000research.132157.1 · Cited by 7
Hematologic parameters in coronavirus infection (COVID-19) and their clinical implications
Waleed, R. M., Sehar, I., Iftikhar, W., & Khan, H. S. (2020) · Discoveries · doi:10.15190/d.2020.14 · Cited by 7
Novel ACE2 protein interactions relevant to COVID-19 predicted by evolutionary rate correlations
Varela, A., Cheng, S., & Werren, J. H. (2021) · PeerJ · doi:10.7717/peerj.12159 · Cited by 7
Aragão, L. G. H. S., Oliveira, J. T., Temerozo, J. R., Mendes, M. A., Salerno, J. A., Pedrosa, C., Puig‐Pijuan, T., Veríssimo, C. P., Ornelas, I. M., Torquato, T., et al. (2021) · PeerJ · doi:10.7717/peerj.12262 · Cited by 7
Kaygusuz, S., Korukluoğlu, G., Coşgun, Y., Şahin, Ö., & Arslan, F. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27751 · Cited by 8
Simões, J. L. B., Sobierai, L. D., Pereira, S. M., dos Santos, M. V. R., & Bagatini, M. D. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220713115906 · Cited by 7
COVID‐19 susceptibility in endometriosis patients: A case control study
Barretta, M., Savasta, F., Pietropaolo, G., di Prun, A. B., Barbera, V., & Vignali, M. (2022) · American Journal of Reproductive Immunology · doi:10.1111/aji.13602 · Cited by 7
Vessel-on-a-Chip: A Powerful Tool for Investigating Endothelial COVID-19 Fingerprints
Shevchuk, O. O., Palii, S. M., Pak, A., Chantada, N., Seoane, N., Korda, M. M., Campos‐Toimil, M., & Álvarez, E. (2023) · Cells · doi:10.3390/cells12091297 · Cited by 7
Shawki, M. A., Elsayed, N. S., Mantawy, E. M., & Said, R. S. (2021) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2021.1931302 · Cited by 7
Immune-based therapeutic approaches in COVID-19
Moeinafshar, A., Yazdanpanah, N., & Rezaei, N. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113107 · Cited by 7
Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infectionPreprint
Sun, C., Fan, J., Huang, J. M., Guo, E., Fu, Y., Liu, S., Xiao, R., Liu, C., Lu, F., Qin, T., et al. (2020) · doi:10.21203/rs.3.rs-86940/v1 · Cited by 7
The kinetics of chemokine autoantibodies in COVID-19
Qi, F., Li, D., & Zhang, Z. (2023) · Nature Immunology · doi:10.1038/s41590-023-01455-8 · Cited by 7
Alveolar cytokines and interferon autoantibodies in COVID-19 ARDS
Jonassen, T. B., Jørgensen, S. E., Mitchell, N. H., Mogensen, T. H., Berg, R. M. G., Ronit, A., & Plovsing, R. R. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1353012 · Cited by 6
Soares, V. C., Dias, S. D. S. G., Santos, J. C., & Bozza, P. T. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae170 · Cited by 6
Ćwilichowska-Puślecka, N., Makowiecka, A., Kalinka, M., Groborz, K. M., Puślecki, T., Drąg, M., Simon, K. A., Dąbrowska, K., Pazgan−Simon, M., & Poręba, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1517933 · Cited by 7
Pathomorphological and Molecular Biological Aspects of Blood Vessel Injury in COVID-19
Есауленко, И. Э., Nikityuk, D. B., Alexeeva, N. Т., Shevchenko, A. A., Соколов, Д. А., Клочкова, С. В., Kvaratskheliya, A. G., Filin, A. A., & Tutelyan, V. A. (2021) · Journal of Anatomy and Histopathology · doi:10.18499/2225-7357-2020-9-4-9-18 · Cited by 7
Segú-Vergés, C., Artigas, L., Coma, M., & Peck, R. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280677 · Cited by 6
Ranjbar, M., Cusack, R. P., Whetstone, C. E., Nawaz, S., Khoury, C. J., Wattie, J. N., Wiltshire, L., Roux, J. L., Cheng, E., Srinathan, T., et al. (2023) · Genes · doi:10.3390/genes14091721 · Cited by 6
Cianciosi, D., Díaz, Y. A., Gaddi, A. V., Capello, F., Savo, M. T., Casanova, R. D. J. P., Espinosa, J. C. M., Barrera, A. E. P., Navarro‐Hortal, M. D., Tian, L., et al. (2023) · Food Frontiers · doi:10.1002/fft2.319 · Cited by 6
Research Advances on the Role of Lipids in the Life Cycle of Human Coronaviruses
Ding, C., Chen, Y., Gen, M., & Qi, Z. (2023) · Microorganisms · doi:10.3390/microorganisms12010063 · Cited by 6
Advance in the mechanism and clinical research of myalgia in long COVID
Zhai, X. (2024) · American journal of clinical and experimental immunology. · doi:10.62347/txvo6284 · Cited by 6
Anfossi, S., Darbaniyan, F., Quinlan, J. J., Calin, S., Shimizu, M., Chen, M., Rausseo, P., Winters, M. T., Bogatenkova, E., Do, K.-A., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02094-9 · Cited by 6
New Points of Departure for More Global Influenza Vaccine Use
Kiseleva, I. (2020) · Vaccines · doi:10.3390/vaccines8030410 · Cited by 6
Lights and Shadows on Managing Immune Checkpoint Inhibitors in Oncology during the COVID-19 Era
Burgaletto, C., Brunetti, O., Munafò, A., Bernardini, R., Silvestris, N., Cantarella, G., & Argentiero, A. (2021) · Cancers · doi:10.3390/cancers13081906 · Cited by 6
Zhan, X.-Y., Li, L., Hu, Y., Li, Q., Kong, H., Ng, M. H. L., Chen, C., He, Y., Huang, B., & Yang, M. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.680604 · Cited by 6
An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system
Hembram, P. (2021) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-021-00582-2 · Cited by 6
Chandar, R., Swaminathan, V. V., Meena, S. K., Varla, H., Uppuluri, R., & Raj, R. (2021) · Pediatric Hematology Oncology Journal · doi:10.1016/j.phoj.2021.12.003 · Cited by 6
Soliman, O. M., Thabet, A. M. A., Abudahab, G. M., & Kamel, E. Z. (2022) · Egyptian Journal of Anaesthesia · doi:10.1080/11101849.2022.2031811 · Cited by 6
Raj, R., Uppuluri, R., Parambil, B. C., Dhariwal, N., Totadri, S., Mathew, L. G., Radhakrishnan, V. S., Charan, A., Yadav, S. P., Mahajan, A., et al. (2022) · Pediatric Hematology Oncology Journal · doi:10.1016/j.phoj.2022.03.002 · Cited by 6
Malik, I. A., & Ramadori, G. P. (2022) · Biology · doi:10.3390/biology11030470 · Cited by 6
Körper, S., Schrezenmeier, E. V., Rincón-Arévalo, H., Grüner, B., Zickler, D., Weiß, M., Wiesmann, T., Zacharowski, K. D., Kalbhenn, J., Bentz, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1008438 · Cited by 6
Mallappa, S., Khatri, A., Gayatri, B. N., & Kulkarni, P. (2022) · Cureus · doi:10.7759/cureus.30129 · Cited by 6
COVID-19 and liver dysfunction in children: Current views and new hypotheses
Yun, Y., Feng, Z., & Zhang, J. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i3.353 · Cited by 6
Mapping the Lipid Signatures in COVID-19 Infection: Diagnostic and Therapeutic Solutions
Dasgupta, A., Gangai, S., Narayan, R., & Kapoor, S. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01238 · Cited by 6
LORENZO, R. D., Mazza, M. G., Sciorati, C., Leone, R., Scavello, F., Palladini, M., Merolla, A., Ciceri, F., Bottazzi, B., Garlanda, C., et al. (2024) · CNS Drugs · doi:10.1007/s40263-024-01081-4 · Cited by 6
NEUROLOGICAL IMPACT OF COVID-19 PANDEMIC: LESSONS & CAUTIONS
Dutta, D. (2020) · Royal Book Publishing · doi:10.26524/royal.37.5 · Cited by 6
Prevalence of SARS-CoV-2 in Patients with Severe Pneumonia in Khuzestan Province, Iran
Abolnezhadian, F., Makvandi, M., Alavi, S. M., Azaran, A., Jalilian, S., Rashno, M. M., Kaydani, G. A., Arshadi, M., Hosseinizadeh, S. M., Boostani, H., et al. (2020) · Iranian Journal of Allergy Asthma and Immunology · doi:10.18502/ijaai.v19i5.4462 · Cited by 6
THE EFFECTS OF COVID19 PANDEMIC UPON TOURISM: A SAMPLE FROM THE CITY OF KARS
Kaygın, E., & Topçuoğlu, E. (2020) · Mehmet Akif Ersoy Üniversitesi İktisadi ve İdari Bilimler Fakültesi Dergisi · doi:10.30798/makuiibf.793095 · Cited by 6
Sobh, E., Reihan, M. S., Hifnawy, T. M. S., Abdelsalam, K. G., Awad, S. S., Mahmoud, N. M. H., Sindi, N., & Alhadrami, H. A. (2021) · The Egyptian Heart Journal · doi:10.1186/s43044-021-00202-4 · Cited by 6
Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment
Primorac, D., Čemerin, M., Matišić, V., Molnar, V., Strbad, M., Girandon, L., Zenić, L., Knežević, M., Minger, S. L., & Polančec, D. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091481 · Cited by 6
Mughal, M. S., Kaur, I. P., Wang, C., Alhashemi, R., BUEMIO, A., Patton, C. D., & Granet, K. M. (2021) · Journal of Investigative Medicine · doi:10.1136/jim-2021-001876 · Cited by 6
Transcriptome analysis of host response to porcine epidemic diarrhea virus nsp15 in IPEC-J2 cells
Ouyang, T., Yang, Z., Wan, J., Zhang, Y., Wang, X., Kong, L., Wang, T., & Li, Y. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.105195 · Cited by 6
Chen, Y., Zhuang, Z., Yang, J., & Bai, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.770910 · Cited by 6
Post SARS-CoV-2 Guillain-Barré syndrome in a child: case report and review of the literature
Jaberi, M. A., Shihadat, R., & Masri, A. T. (2022) · Child s Nervous System · doi:10.1007/s00381-022-05536-1 · Cited by 6
Ghaempanah, F., Nikouei, M., Cheraghi, M., Jahangiri, A., & Moradi, Y. (2023) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-023-00662-w · Cited by 6
SARS-CoV-2 / COVID-19 and its Transmission, Prevention, Treatment and Control - An Update
Sharma, P., Tripathi, S., Patel, S. K., Dhama, K., & Chandra, R. (2020) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.14.spl1.32 · Cited by 7
Metadata
- Authors
- Coperchini, F., Chiovato, L., Croce, L., Magri, F., & Rotondi, M.
- Affiliations
- Istituti Clinici Scientifici Maugeri (IT)
- University of Pavia (IT)
- Corresponding author
- Rotondi, Mario
- Venue
- Cytokine & Growth Factor Reviews
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 53
- Pages
- 25-32
- ISSN
- 1359-6101 (ISSN-L)
- PMC
- PMC7211650
- OpenAlex
- W3021577619
- Cited by
- 1,288
- References
- 106
- Citations by year
- 2026: 20 · 2025: 44 · 2024: 92 · 2023: 158 · 2022: 274 · 2021: 443 · 2020: 257
- FWCI
- 13.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cytokine & Growth Factor Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- cytokine storm, COVID-19 pandemic, SARS-CoV-2, chemokines, chemokine receptors, acute respiratory distress syndrome, systemic inflammation, immune cell recruitment, SARS, MERS, betacoronaviruses, disease severity
- MeSH terms
- Betacoronavirus, Cytokine Release Syndrome, COVID-19, SARS-CoV-2, Humans, Pneumonia, Viral, Coronavirus Infections, Chemokines, Receptors, Chemokine, Severe Acute Respiratory Syndrome, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
